Yoshiki Sakai

This inventor holds 11 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Ono Pharmaceutical Co., Ltd., Osaka University, Cuorips Inc.. Active years: 1984-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiki Sakai. Retrieved from https://idiyas.com/inventor/yoshiki-sakai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 72.7

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Mishima, JP (1984)
Mishimagun, JP (1985 - 2013)
Osaka, JP (1984 - 2014)
Sasayama, JP (2017)
Suita, JP (2018)

Company Filing History:

10 out of 575

Ono Pharmaceutical Co., Ltd.

where one patent can have more than one assignee

Years Active: 1984-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569437 - Disease-site-specific liposomal formulation (2026-03-10),

2. 9968716 - Drug-eluting stent graft (2018-05-15),

3. 9597436 - Advanced heart failure treatment material as myocardial/cardiovascular regeneration device (2017-03-21),

4. 8642630 - Endogeneous repair factor production accelerators (2014-02-04),

5. 8617614 - Sustained release preparation for tissue regeneration therapy (2013-12-31),

6. 8436026 - Endogeneous repair factor production promoters (2013-05-07),

7. 7671057 - Therapeutic agent for type II diabetes comprising protease-inhibiting compound (2010-03-02),

8. 7547715 - Endogenous repair factor production accelerator (2009-06-16),

9. 4503068 - Use of prostaglandin analogues to treat cytodamage (1985-03-05),

10. 4473587 - Prostaglandin E.sub.1 analogues (1984-09-25),

11. 4464388 - Use of prostaglandin analogues to treat cytodamage (1984-08-07),

Title: Innovations by Yoshiki Sakai

Introduction

Yoshiki Sakai is a prominent inventor based in Mishima-gun, Japan. He has made significant contributions to the field of medical devices, particularly in cardiovascular treatments. With a total of 10 patents to his name, his work focuses on innovative solutions for complex health issues.

Latest Patents

One of his latest inventions is a drug-eluting stent graft designed to prevent stent graft-related complications while treating aneurysms. This invention comprises a drug, a drug-retaining agent, and a stent graft, along with a method for therapy involving the use of this graft. Another notable patent is an advanced heart failure treatment material that serves as a myocardial/cardiovascular regeneration device. This device self-assembles and can be used in emergencies without the need for cell culturing. It aims to improve the quality of life for patients suffering from advanced heart failure and other intractable cardiovascular diseases.

Career Highlights

Yoshiki Sakai has worked with notable organizations such as Ono Pharmaceutical Co., Ltd. and Osaka University. His experience in these institutions has contributed to his expertise in developing innovative medical solutions.

Collaborations

Some of his coworkers include Akio Nishiura and Teppei Ogata, who have collaborated with him on various projects.

Conclusion

Yoshiki Sakai's contributions to medical innovation, particularly in cardiovascular treatments, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving patient outcomes and advancing medical technology.

Profile summary based on public USPTO records.